Abstract
The effectiveness of a vaccine depends on vaccine uptake, which is influenced by various factors, including vaccine hesitancy. Vaccine hesitancy is a complex socio-behavioral issue, influenced by misinformation, distrust in healthcare providers and government organizations, fear of side effects, and cultural or religious beliefs. To address this problem, AI models have been developed, but their global generalizability remains unclear. Therefore, this study aimed to identify global determinants of vaccine uptake and develop a generalizable machine learning model to predict individual-level vaccine uptake. The study used publicly available survey data from 23 countries and employed Bayesian networks and generalized mixed effects models to identify key determinants of vaccine uptake. The results showed that trust in the central government and vaccination restrictions for national and international travel were key determinants of vaccine uptake. A generalized mixed effects model achieved an AUC of 89% (SD=1%), precision of 90% (SD = 4%), and recall of 82% (SD=2%) on unseen testing data from new countries, demonstrating the model’s generalizability. The findings of this study can inform targeted interventions to improve vaccine uptake globally.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NA
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Made correction with the language.
